C. B. Todd

C. B. Todd discloses dealings in Mylan Laboratories Inc to SEC (Form 4). In total, 27 filings cover trades dated from 27 July 2007 to 14 March 2014.

Both buying and selling appear: 3 purchases worth €123k, against 9 sales worth €11.9M. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants and 11 option exercises. In 2014 alone, the filings show no purchases and 1 sale.

Most recently, on 14 March 2014, the filings show an option exercise worth €107k in Mylan Laboratories Inc. The clock since the last published purchase (27 July 2007) now reads 7,045 days. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.